Big Gains Coming up in March for LLY

Eli Lilly has two press releases coming up next month, and considering the stability of this company, this could probably the easiest 10-20% you've ever made. The first press release is a phase 2 trial update for their drug, Donanemab (TRAILBLAZER-ALZ) for Alzheimer's. The second release is a meeting to schedule a PDUFA approval on the 24th. I will be selling after this meeting. Good Luck!